WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns

Credit: Reuters India- Published on May 26, 2020
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
Advertisement

You are here

Related videos from verified sources

CORONAVIRUS: New clinical trial begins at Stanford of a new procedure to treat COVID-19 patients 02:02
Credit: CBS 5 SF KPIX - Published on May 14, 2020 


Photos Of Packed Flight To SFO During COVID-19 Pandemic Raise Safety Concerns 02:11
Credit: CBS 5 SF KPIX - Published on May 12, 2020 


Hydroxycholoroquine Failed To Help COVID-19 Victims In 2 Studies 00:35
Credit: Wochit - Published on May 11, 2020 


Related news from verified sources

A clinical trial of malaria drug hydroxychloroquine in COVID-19 patients has been suspended amid safety concerns, World Health Organization (WHO Director General...
on May 25, 2020 • Reuters

Sanofi has temporarily stopped recruiting new COVID-19 patients for its two clinical trials on hydroxychloroquine and will not supply the anti-malaria drug to...
on May 29, 2020 • Reuters

No major side-effects of Hydroxychloroquine (HCQ) have been found in studies in India and its use should be continued in preventive treatment for Covid-19, the...
on May 26, 2020 • IndiaTimes

You might like